Kowluru Renu A, Shan Yang
Kresge Eye Institute, Wayne State University, Detroit, MI, 48201, USA.
Graefes Arch Clin Exp Ophthalmol. 2017 May;255(5):955-962. doi: 10.1007/s00417-017-3594-0. Epub 2017 Jan 25.
In the pathogenesis of diabetic retinopathy, damaged retinal mitochondria accelerate apoptosis of retinal capillary cells, and regulation of oxidative stress by manipulating mitochondrial superoxide dismutase (SOD2) protects mitochondrial homeostasis and prevents the development of diabetic retinopathy. Diabetes also activates matrix metalloproteinase-9 (MMP-9), and activated MMP-9 damages retinal mitochondria. Recent studies have shown a dynamic DNA methylation process playing an important role in regulation of retinal MMP-9 transcription in diabetes; the aim of this study is to investigate the role of oxidative stress in MMP-9 transcription.
The effect of regulation of mitochondrial superoxide on DNA methylation of MMP-9 promoter region was investigated in retinal endothelial cells incubated in the presence or absence of a MnSOD mimetic MnTBAP, by quantifying the levels of 5 methyl cytosine (5mC) and hydroxyl-methyl cytosine (5hmC). The binding of DNA methylating, and of hydroxymenthylating enzymes (Dnmts and Tets, respectively), at MMP-9 promoter (by chromatin immunoprecipitation) was also evaluated. The in vitro results were confirmed in the retina of diabetic mice overexpressing SOD2.
MnTBAP attenuated glucose-induced decrease in 5mC levels and increase on Dnmt1 binding at the MMP-9 promoter region. MnTBAP also ameliorated alterations in 5hmC levels and Tet binding, regulated MMP-9 transcription, and prevented mitochondrial damage. Similarly, mice overexpressing SOD2 were protected from diabetes-induced alteration in MMP-9 promoter methylation, and its transcription.
Thus, regulation of oxidative stress by pharmacologic/genetic approaches maintains retinal mitochondrial homeostasis by ameliorating epigenetic modifications in the MMP-9 promoter region.
在糖尿病视网膜病变的发病机制中,受损的视网膜线粒体加速视网膜毛细血管细胞凋亡,通过操纵线粒体超氧化物歧化酶(SOD2)调节氧化应激可保护线粒体稳态并预防糖尿病视网膜病变的发展。糖尿病还会激活基质金属蛋白酶-9(MMP-9),而活化的MMP-9会损害视网膜线粒体。最近的研究表明,动态DNA甲基化过程在糖尿病视网膜MMP-9转录调控中起重要作用;本研究的目的是探讨氧化应激在MMP-9转录中的作用。
通过定量5-甲基胞嘧啶(5mC)和羟甲基胞嘧啶(5hmC)水平,研究在存在或不存在锰超氧化物歧化酶模拟物MnTBAP的情况下培养的视网膜内皮细胞中线粒体超氧化物调节对MMP-9启动子区域DNA甲基化的影响。还评估了DNA甲基化酶和羟甲基化酶(分别为Dnmts和Tets)在MMP-9启动子处的结合(通过染色质免疫沉淀法)。在过表达SOD2的糖尿病小鼠视网膜中证实了体外实验结果。
MnTBAP减轻了葡萄糖诱导的MMP-9启动子区域5mC水平降低和Dnmt1结合增加。MnTBAP还改善了5hmC水平和Tet结合的改变,调节了MMP-9转录,并预防了线粒体损伤。同样,过表达SOD2的小鼠免受糖尿病诱导的MMP-9启动子甲基化及其转录改变的影响。
因此,通过药理学/遗传学方法调节氧化应激可通过改善MMP-9启动子区域的表观遗传修饰来维持视网膜线粒体稳态。